The ESVM
Academy

09:30 – 10:00

Welcome and opening remarks

(Mazzolai L, Madaric J)

10:00 – 12:00

Workshops – Vascular Ultrasound

Workshop no. 1: Colour duplex ultrasound of arterial disease (Flak L, Dzupina A jr)

Workshop no. 2: Ultrasound of venous disease (Sirila M, Pataky S)

12:00 – 13:00

Lunch break

13:00 – 14:45

Workshops – Vascular Ultrasound

Workshop no. 1: Colour duplex ultrasound of arterial disease (Flak L, Dzupina A jr)

Workshop no. 2: Ultrasound of venous disease (Sirila M, Pataky S)

14:45 – 15:00

Coffee break

15:00 – 17:00

Management of Peripheral Artery Disease from A to Z

(Brodmann M, Madaric J)

Discussion facilitator: Flak L

1. Pitha J. Atherosclerosis, current concept
2. Vacula I. Diagnostic algorithm of PAD
3. Espinola‑Klein Ch. Best medical treatment of PAD patients
4. Brodmann M. Lower extremity revascularisation – endovascular versus surgical treatment – proper indications
5. Madaric J. Regeneration therapy in patients with no-option critical limb ischemia.

08:30 – 10:00

Chronic venous disease, lymphatic disease – up to date

(Mazzolai L, Stvrtinova V)

Discussion facilitator: Dzupina A jr.

1. Celovska D. Epidemiology, risk factors and diagnosis of chronic venous disease.
2. Stvrtinova V. Conservative management of CVD – from compression to pharmacotherapy.
3. Sumaj M. Endovenous therapy of CVD
4. Mazzolai L. Lymphedema or lipedema?

10:00 – 10:15

Coffee break

10:15 – 12:00

Venous thromboembolism – current evidence

(Bura‑Riviere A, Schlager O)

Discussion facilitator: Vacula I

1. Mazzolai L. VTE: from diagnosis to treatment and follow up
2. Bura‑Riviere A. Management of VTE and anticoagulation in women
3. Flak L. Management of PE – current guidelines
4. Schlager O. When is endovascular therapy indicated in patients with DVT and PE?

12:00 – 13:00

Lunch break

13:00 – 14:45

Carotid arteries and aorta

(Espinola‑Klein Ch, Varejka P)

Discussion facilitator: Pataky S

1. Brodmann M. Carotid artery disease – current evidence of treatment
2. Varejka P. Type B aortic dissection – diagnosis and endovascular therapy
3. Espinola‑Klein Ch. Screening and follow-up of patients with AAA
4. Spak L. Current treatment of pts with AAA

14:45 – 15:00

Coffee break

15:00 – 17:00

Vascular Medicine – Varia

(Schlager O, Bura‑Riviere A)

Discussion facilitator: Celovska D

1. Rasiova M. Vasculitis – basic principles of diagnosis and treatment
2. Kopalova I. Vascular malformations – current concept
3. Schlager O. Buerger disease
4. Bura‑Riviere A. Raynaud syndrome: from diagnosis to treatment
5. Madaric J. What is significant renal artery stenosis?

08:30 – 10:00

Clinical cases discussion 1

(Mazzolai L, Pitha J)

Discussion facilitator: Flak L

10:00 – 10:15

Coffee break

10:15 – 12:00

Clinical cases discussion 2

(Madaric J, Brodmann M)

Discussion facilitator: Celovska D

12:00

Closing remarks

(Mazzolai L, Madaric J)